Early-stage lung cancer usually refers to stages 1, 2, and 3A non-small cell lung cancer (NSCLC) as well as limited-stage small cell lung cancer (SCLC). You may have no symptoms in these early ...

For patients with stage IA non-small cell lung cancer (NSCLC), lung resections, including lobectomy and segmentectomy, are ...

NSCLC: Non-small cell lung cancer, a type of lung cancer that includes several subtypes, such as adenocarcinoma and squamous cell carcinoma. TNM Staging System: A classification system that ...

A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled “Acquired RUFY1-RET rearrangement as a ...

This guide will help you understand how NSCLC is treated, potential side effects, and how to navigate life beyond cancer.

While surgery has been a primary treatment option for some early-stage NSCLC patients, recurrence rates of 30% to 55% highlight the need for additional perioperative interventions. “Given the ...

Researchers found that, in patients with stage III NSCLC, treatment with cCRT and an ICI was safe, but treatment with cCRT and 2 ICIs led to “excessive mortality.” ...

The CONVERGE study evaluates NBTXR3's efficacy in stage III unresectable NSCLC with standard chemoradiation and durvalumab. NBTXR3, a hafnium oxide nanoparticle, is activated by radiotherapy to induce ...

DelveInsight’s c-MET-NSCLC pipeline report depicts a robust space with 20+ active players working to develop 20+ pipeline ...

Standard treatment for stage 1 NSCLC is tumour resection, but up to 40% of patients may experience disease recurrence. Tumour resection is typically followed by observation but adjuvant chemotherapy ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...